| Structure | Chemical Name | CAS | MF |
|
2-Butanone, 4-(4,5-dihydro-2-oxazolyl)- (9CI)
|
158264-69-8
|
C7H11NO2
|
|
4-Quinolineacetic acid, Methyl ester
|
158265-22-6
|
C12H11NO2
|
|
4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine
|
158271-18-2
|
C15H19N
|
|
(R)-1-(2-Hydroxy-1-phenylethyl)-1,5-dihydropyrrol-2-one
|
158271-95-5
|
C12H13NO2
|
|
Ustiloxin C
|
158274-98-7
|
C23H34N4O10S
|
|
callitachykinin I
|
158275-30-0
|
C46H69N13O11
|
|
callitachykinin II
|
158275-31-1
|
C48H79N17O13
|
|
1-Ethoxycarbonyl-5-methyl-(3R)-3-tert-butyl-dimethylsilyloxypentanedioate
|
158275-79-7
|
C15H28O7Si
|
|
H-LYS(NICOTINOYL)-OH HCL
|
158276-23-4
|
C12H17N3O3
|
|
4-amino-N-(2,6-dimethylphenyl)phthalimide
|
158276-70-1
|
C16H14N2O2
|
|
2-Propenoic acid, 2-methyl-, butyl ester, polymer with dodecyl 2-methyl-2-propenoate, 1-ethenyl-2-pyrrolidinone, hexadecyl 2-methyl-2-propenoate, octadecyl 2-methyl-2-propenoate and tetradecyl 2-methyl-2-propenoate
|
158282-45-2
|
C90H167NO11
|
|
4-AMINO-3-CHLORO-5-METHYLBENZONITRILE
|
158296-69-6
|
C8H7ClN2
|
|
3-(2-Bromo-1-oxopropyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexan]-4(3H)-one
|
158299-05-9
|
C16H18BrNO3
|
|
Carbamic acid, (1,3-dimethyl-2-butenyl)-, 1,1-dimethylethyl ester, (R)- (9CI)
|
158300-08-4
|
C11H21NO2
|
|
Carbamic acid, (1,3-dimethyl-2-butenyl)-, 1,1-dimethylethyl ester, (S)- (9CI)
|
158300-09-5
|
C11H21NO2
|
|
N(6)-(1,3-dimethyl-2-butenyl)adenine
|
158300-13-1
|
C11H15N5
|
|
Adenosine, N-(1,3-dimethyl-2-butenyl)-, (R)-
|
158300-15-3
|
C16H23N5O4
|
|
Aziridine, 1-(iminophenylmethyl)- (9CI)
|
158305-11-4
|
C9H10N2
|
|
N-stearoylglycine
|
158305-64-7
|
C20H39NO3
|
|
HYDROXYETHYL ISOSTEARYLOXY ISOPROPANOLAMINE
|
158314-47-7
|
C23H49NO3
|
|
Bectumomab
|
158318-63-9
|
|
|
|
Fatty acids, C8-10, ethoxylated, reaction products with epoxidized soybean oil
|
158318-70-8
|
|
|
CTC 96
|
158318-97-9
|
C20H30BrCoN6O2
|
|
3-ETHYL-2-[(3-([3-ETHYL-5-METHOXY-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]METHYL)-5,5-DIMETHYL-2-CYCLOHEXEN-1-YLIDENE)METHYL]-5-METHOXY-1,3-BENZOTHIAZOL-3-IUM IODIDE
|
158320-43-5
|
C30H35IN2O2S2
|
|
1-Nitro-2-aminocarbazole
|
158321-20-1
|
C12H9N3O2
|
|
7-broMo-4,4-diMethyl-1,2,3,4,-tetrahydroquinoline
|
158326-77-3
|
C11H14BrN
|
|
6-broMo-3,3-diMethylindolin-2-one
|
158326-84-2
|
C10H10BrNO
|
|
6-broMo-3,3-diMethylindoline
|
158326-85-3
|
C10H12BrN
|
|
4-Amino-6-methyl-3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine hydrochloride
|
158329-07-8
|
C4H9ClN4O
|
|
5-BROMO-1-CHLOROINDANE
|
158330-91-7
|
C9H8BrCl
|
|
3-BROMO-6,7-DIHYDRO-5H-[1]PYRINDINE
|
158331-18-1
|
C8H8BrN
|
|
24-methyllanosta-8-en-22,28-epoxy-3,28-diol
|
158331-65-8
|
C31H52O3
|
|
YF 044P-D
|
158335-52-5
|
C43H57N5O9
|
|
(TETRA-T-BUTYLPHTHALOCYANINATO)LEAD(II)
|
158335-62-7
|
C48H48N8Pb
|
|
pseudostellarin D
|
158335-65-0
|
C36H55N7O8
|
|
(1.Alpha.,3a.alpha.,6a.alpha.)-Hexahydro-4-oxo-cyclopenta[c]pyrrole-1,2(1H)-dicarboxylicacid-1-ethyl2-(phenylmethyl)ester
|
158340-62-6
|
C18H21NO5
|
|
1,2-Cyclopentanedimethanol,4-amino-,[1S-(1alpha,2beta,4alpha)]-(9CI)
|
158340-66-0
|
C7H15NO2
|
|
2,6-Methano-1H-pyrrolizine-1-carbonitrile,hexahydro-,[1R-(1alpha,2alpha,6alpha,7abeta)]-
|
158341-53-8
|
C9H12N2
|
|
(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE
|
158342-64-4
|
C19H27BrO2
|
|
|
2-Propenoic acid, 2-methyl-, octadecyl ester, polymer with 1,1-dichloroethene and .alpha.-fluoro-.omega.-2-(1-oxo-2-propenyl)oxyethylpoly(difluoromethylene)
|
158343-13-6
|
|
|
4H-Pyran-4-one, tetrahydro-3-(trifluoroacetyl)- (9CI)
|
158351-87-2
|
C7H7F3O3
|
|
PYRACLONIL
|
158353-15-2
|
C15H15ClN6
|
|
1,1,7-trichloro-1-hepten-3-one
|
158355-41-0
|
C7H9Cl3O
|
|
Pyrazolo[1,5-a]pyridin-2(1H)-one, 4,5,6,7-tetrahydro-, hydrazone (9CI)
|
158355-42-1
|
C7H12N4
|
|
3H-Pyrazol-3-one, 1,2-dihydro-1-methyl-5-(methylthio)-, hydrazone (9CI)
|
158355-44-3
|
C5H10N4S
|
|
1-Methyl-5-(Methylthio)-1H-Pyrazol-3-Amine
|
158355-45-4
|
C5H9N3S
|
|
1,3-Dioxolane-2-propanal, 2-ethenyl-
|
158355-63-6
|
C8H12O3
|
|
|
GE 68
|
158358-22-6
|
C21H25NO2
|
|
NIR-667 N-SUCCINIMIDYL ESTER
|
158358-57-7
|
C30H35ClN4O5
|
|
(R)-(+)-3,3-DIFLUORO-1,2-HEPTANEDIOL
|
158358-96-4
|
C7H14F2O2
|
|
2-Furancarboxaldehyde, 4-(hydroxymethyl)-
|
158360-01-1
|
C6H6O3
|
|
Ethanone, 1-(4-fluorophenyl)-, oxime, (1E)- (9CI)
|
158364-41-1
|
C8H8FNO
|
|
Carbamic acid,N-[2-[[(2,3-dimethylimidazo[1,2-a]pyridin-8-yl)amino]methyl]-3-methylphenyl]-,methyl ester
|
158364-59-1
|
C19H22N4O2
|
|
2-Fluoro-4-methylBenzotrifluoride
|
158364-83-1
|
C8H6F4
|
|
pedoxin
|
158365-17-4
|
C10H10N2O3
|
|
(5R,6S)-6-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 2-propenyl ester
|
158365-51-6
|
C12H18NNaO6S
|
|
7-METHOXY-1-NAPHTHONITRILE
|
158365-54-9
|
C12H9NO
|
|
7-Methoxynaphthalene-1-carboxaldehyde
|
158365-55-0
|
C12H10O2
|
|
4H-Imidazol-4-one,1,5-dihydro-2-propyl-(9CI)
|
158365-96-9
|
C6H10N2O
|
|
2-BUTYL-5-CHLORO-1H-IMIDAZOLE
|
158365-99-2
|
C7H11ClN2
|
|
Ethanone, 1-(1-nitro-1H-pyrrol-2-yl)- (9CI)
|
158366-45-1
|
C6H6N2O3
|
|
chloro(ethylenediamine)(1-methylimidazole-N(3))platinum(II)
|
158366-92-8
|
C6H14ClN5O3Pt
|
|
phyD phytochrome
|
158379-16-9
|
C61H96N16O19S
|
|
[R-(R*,S*)]-3-tert-Butylcarbamoyl-4-oxiranylmethyl-piperazine-1-carboxylic acid tert-butyl ester
|
158380-45-1
|
C17H31N3O4
|
|
(2R)-L-gamma-Glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy) ethyl)sulfonyl)- L-alanyl-2-phenylglycine
|
158382-37-7
|
C26H40Cl4N5O10PS
|
|
3-(2-METHYL-3-FURYL)-3-OXOPROPANENITRILE
|
158386-97-1
|
C8H7NO2
|
|
2-IODOBENZOYLACETONITRILE
|
158387-19-0
|
C9H6INO
|
|
5-chloro-6-methoxypyridin-3-amine
|
158387-20-3
|
C6H7ClN2O
|
|
2,2,2-TRIFLUORO-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYLAMINE
|
158388-49-9
|
C9H7F6N
|
|
Oxiranecarboxaldehyde, 3-(3-methyl-2-butenyl)-, (2R-trans)- (9CI)
|
158391-38-9
|
C8H12O2
|
|
Oxiranecarboxaldehyde, 3-(3-pentenyl)-, [2R-[2alpha,3beta(E)]]- (9CI)
|
158391-39-0
|
C8H12O2
|
|
Methyl (2S)-1-(tert-butoxycarbonyl)-4,4-dimethylpyroglutamate
|
158392-74-6
|
C13H21NO5
|
|
(S)-1-tert-butyl 2-ethyl 4,4-dimethyl-5- oxopyrrolidine-1,2-dicarboxylate
|
158392-80-4
|
C14H23NO5
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-hydroxy-, (7R-cis)- (9CI)
|
158393-18-1
|
C7H12N2O2
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-hydroxy-2-methyl-, (7R-cis)- (9CI)
|
158393-19-2
|
C8H14N2O2
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, 2-ethylhexahydro-7-hydroxy-, (7R-cis)- (9CI)
|
158393-20-5
|
C9H16N2O2
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-hydroxy-4-methyl-, [4R-(4-alpha-,7-ba-,8a-ba-)]- (9CI)
|
158393-21-6
|
C8H14N2O2
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-mercapto-, (7S-trans)- (9CI)
|
158393-26-1
|
C7H12N2OS
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-mercapto-2-methyl-, (7S-trans)- (9CI)
|
158393-27-2
|
C8H14N2OS
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, hexahydro-7-mercapto-4-methyl-, [4R-(4-alpha-,7-alpha-,8a-ba-)]- (9CI)
|
158393-29-4
|
C8H14N2OS
|
|
1-(6-METHOXYPYRIDIN-3-YL)PIPERAZINE
|
158399-76-9
|
C10H15N3O
|
|
2,2,2-trifluoro-1-(3,4,5-trichlorophenyl)ethanone
|
158401-00-4
|
C8H2Cl3F3O
|
|
Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride)
|
158401-51-5
|
C7H19Cl2N2O4P
|
|
3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane
|
158401-52-6
|
C7H16ClN2O3P
|
|
(S)-tert-Butyl 3-(bromomethyl)piperidine-1-carboxylate
|
158406-99-6
|
C11H20BrNO2
|
|
4-Bromomethypiperidine-1-carboxylic acid tert-butyl ester
|
158407-04-6
|
C11H20BrNO2
|
|
4,8-Methano-1,3-dioxolo[4,5-d]oxepin-5-ol,hexahydro-2,2-dimethyl-,[3aR-(3a-alpha-,4-bta-,5-bta-,8-bta-,8a-alpha-)]-(9CI)
|
158413-30-0
|
C10H16O4
|
|
4,8-Methano-1,3-dioxolo[4,5-d]oxepin-5-ol,hexahydro-2,2-dimethyl-,[3aR-(3a-alpha-,4-bta-,5-alpha-,8-bta-,8a-alpha-)]-(9CI)
|
158413-31-1
|
C10H16O4
|
|
(S)-AMINO-(3-NITRO-PHENYL)-ACETIC ACID
|
158413-55-9
|
C8H8N2O4
|
|
(1R,2R)-(-)-2-Amino-1-cyclopentanecarboxylic acid hydrochloride
|
158414-44-9
|
C6H12ClNO2
|
|
(1S,2R)-(+)-2-AMINOCYCLOHEXANECARBOXYLIC ACID HYDROCHLORIDE
|
158414-45-0
|
C7H14ClNO2
|
|
(1R,2R)-2-Aminocyclohexanecarboxylic acid hydrochloride
|
158414-46-1
|
C7H14ClNO2
|
|
(1R,2S)-(-)-2-AMINOCYCLOHEXANECARBOXYLIC ACID HYDROCHLORIDE
|
158414-48-3
|
C7H14ClNO2
|
|
1,3-Benzenedicarboxylic acid polymer with 1,4-Benzenedicarb oxylic acid, 1,4-butanediol, 2,2-[1,2-ethanedyilbis(oxy)]bis [etha nol] and 2,2′-oxybis[ethanol]
|
158415-47-5
|
C30H46O17
|
|
|
transcription factor TFIIIR
|
158415-69-1
|
|
|
1,7-Cyclooctadiene-1-carboxylicacid(9CI)
|
158426-76-7
|
C9H12O2
|
|
2-CYCLOPENTYLOXY-3-METHOXY-BENZALDEHYDE
|
158429-01-7
|
C13H16O3
|
|
4-(Methoxycarbonyl)-2-methylphenylboronic acid
|
158429-38-0
|
C9H11BO4
|
|
3-(CYCLOPENTYLOXY)-4-METHOXYBENZAMIDE
|
158429-58-4
|
C13H17NO3
|
|
(2-METHYL-4-CARBOXYPHENYL)BORONIC ACID
|
158429-66-4
|
C8H9BO4
|